Pediatric Multicenter Study of REPEL-CV
Phase 2
- Conditions
- Adhesions
- Registration Number
- NCT00116233
- Lead Sponsor
- SyntheMed
- Brief Summary
This trial will study REPEL-CV for reducing post operative adhesions following cardiovascular (cv) surgery.
- Detailed Description
- Efficacy at second sternotomy
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Stage sternotomies
Exclusion Criteria
- Delayed closure beyond 5 days
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
SyntheMed
🇺🇸Little Silver, New Jersey, United States